Phase
Condition
Dystonia
Dyskinesias
Treatment
ExAblate Transcranial treatment
Clinical Study ID
Ages 21-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Clinical diagnosis of moderate to severe TSFD with impact in their daily function oroccupation function
Patients who failed to response or had unsatisfactory response to the firsttreatment, such as Botulinum toxin treatment or DBS or refuse these alternativeoptions
Age greater than 21 and less than 75 years
Subjects who are able and willing to give consent and able to attend all studyvisits,
Documented chronic, symptoms for more than 6 months duration
Pallidotomy is feasible based on evaluation of imaging studies
Patient able to communicate sensations during the ExAblate TcMRgFUS treatment
Two members of the medical team have agreed upon inclusion and exclusion criteria
Exclusion
Exclusion Criteria:
Patient with contraindications to MRI such as severe claustrophobia and metallicimplants incompatible with MRI.
Presence of generalized dystonia or involvement of two or more contiguous bodyregions (such as Arm along with neck)
Severe psychiatric disorder such as uncontrolled depression, anxiety, bipolardisorder, prior attempt at suicide or suicide ideation in preceding 12 months
Life expectancy less than 12 months
Anticoagulant or antiplatelet medications as well as underlying coagulopathy
Pregnant ladies or women of childbearing age who are sexually active and not usingcontraception
Inability to provide informed consent, for example due to underlying cognitiveimpairment or aphasia
Presence of intracranial mass or an acute intracranial abnormality
Subjects with unstable cardiac status such as unstable angina pectoris, documentedmyocardial infarction within 6 months of protocol entry or ejection fraction lessthan 40
Subjects exhibiting any behavior(s) consistent with ethanol or substance abuse asdefined by the criteria outlined in the Diagnostic and Statistical Manual of MentalDisorders(DSM-IV)
Severe hypertension (diastolic blood pressure > 100 on medication or persistentlyelevated systolic blood pressure>140 mmHg despite adequate antihypertensivemedications)
History of intracranial hemorrhage, traumatic brain injury or thalamic stroke.
Cerebrovascular disease (multiple cerebrovascular accident's (CVA) or CVA within 6months)
Subjects with life-threatening systemic disease that include and not limited to thefollowing will be excluded from the study participation: HIV, Liver Failure, blooddyscrasias, etc.
Subjects with a history of seizures within the past year
Individuals who are not able or willing to tolerate the required prolongedstationary supine position during treatment (can be up to 4 hours of total tabletime.)
Study Design
Study Description
Connect with a study center
University of Maryland Medical Center
Baltimore, Maryland 21201
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.